Quantitative EEG and cholinergic basal forebrain atrophy in Parkinson's disease and mild cognitive impairment

Cholinergic degeneration is a key feature of dementia in neurodegenerative conditions including Alzheimer's disease (AD) and Parkinson's disease (PD). Quantitative electro-encephalography (EEG) metrics are altered in both conditions from early stages, and recent research in people with Lewy body and AD dementia suggests these changes may be associated with atrophy in cholinergic basal forebrain nuclei (cBF). To determine if these relationships exist in predementia stages of neurodegenerative conditions, we studied resting-state EEG and in vivo cBF volumes in 31 people with PD (without dementia), 21 people with mild cognitive impairment (MCI), and 21 age-matched controls. People with PD showed increased power in slower frequencies and reduced alpha reactivity compared to controls. Volumes of cholinergic cell clusters corresponding to the medial septum and vertical and horizontal limb of the diagonal band, and the posterior nucleus basalis of Meynert, correlated positively with; alpha reactivity in people with PD ( p < 0.01); and pre-alpha power in people with MCI ( p < 0.05). These results suggest that alpha reactivity and pre-alpha power are related to changes in cBF volumes in MCI and PD without dementia. (c) 2021 Elsevier Inc. All rights reserved.

Automated summary

Cholinergic degeneration is a key feature of dementia in neurodegenerative conditions, and recent research suggests that changes in EEG metrics may be associated with atrophy in cholinergic basal forebrain nuclei. The study found that patients with PD have increased power in slower frequencies and reduced alpha reactivity compared to controls. Additionally, volumes of cholinergic cell clusters correlated positively with EEG metrics in PD and MCI patients.